Catalyst Funds Management Pty Ltd Reduces Holdings in Astera Labs, Inc. $ALAB

Posted by Stanley Muller on May 24th, 2026

Catalyst Funds Management Pty Ltd decreased its position in Astera Labs, Inc. (NASDAQ:ALAB – Free Report) by 21.6% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 16,300 shares of the company’s stock after selling 4,500 shares during the period. Catalyst Funds Management Pty Ltd’s holdings in Astera Labs were worth $2,712,000 at the end of the most recent quarter.

Other hedge funds have also made changes to their positions in the company. Assetmark Inc. boosted its position in shares of Astera Labs by 374.1% during the 3rd quarter. Assetmark Inc. now owns 128 shares of the company’s stock worth $25,000 after purchasing an additional 101 shares during the period. Wexford Capital LP acquired a new stake in Astera Labs during the 3rd quarter worth approximately $39,000. Hilltop National Bank lifted its holdings in Astera Labs by 100.0% during the 4th quarter. Hilltop National Bank now owns 200 shares of the company’s stock worth $33,000 after buying an additional 100 shares in the last quarter. Aventura Private Wealth LLC acquired a new stake in shares of Astera Labs in the 4th quarter valued at $33,000. Finally, National Bank of Canada FI raised its holdings in shares of Astera Labs by 159.0% in the 3rd quarter. National Bank of Canada FI now owns 202 shares of the company’s stock valued at $39,000 after purchasing an additional 124 shares in the last quarter. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Insider Activity at Astera Labs

In related news, General Counsel Philip Mazzara sold 14,076 shares of the business’s stock in a transaction dated Monday, May 18th. The shares were sold at an average price of $231.78, for a total transaction of $3,262,535.28. Following the sale, the general counsel owned 104,139 shares of the company’s stock, valued at approximately $24,137,337.42. The trade was a 11.91% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Jitendra Mohan sold 28,737 shares of the business’s stock in a transaction dated Tuesday, May 19th. The stock was sold at an average price of $249.62, for a total transaction of $7,173,329.94. Following the sale, the chief executive officer directly owned 3,789,232 shares in the company, valued at approximately $945,868,091.84. This represents a 0.75% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 1,915,461 shares of company stock worth $358,508,976 in the last ninety days. Corporate insiders own 12.50% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on ALAB shares. TD Cowen raised their price objective on shares of Astera Labs from $140.00 to $225.00 and gave the company a “hold” rating in a report on Wednesday, May 6th. JPMorgan Chase & Co. lifted their price objective on shares of Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a research note on Wednesday, May 6th. Loop Capital began coverage on shares of Astera Labs in a research note on Thursday, March 5th. They issued a “buy” rating and a $250.00 price objective on the stock. Susquehanna lifted their price objective on shares of Astera Labs from $155.00 to $230.00 and gave the company a “neutral” rating in a research note on Wednesday, May 6th. Finally, Jefferies Financial Group reaffirmed a “buy” rating and issued a $270.00 target price on shares of Astera Labs in a report on Wednesday, May 6th. Fourteen equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $233.75.

Read Our Latest Stock Report on Astera Labs

Astera Labs Trading Up 3.0%

ALAB stock opened at $306.88 on Friday. The company has a market cap of $52.60 billion, a P/E ratio of 207.35, a P/E/G ratio of 4.06 and a beta of 3.35. Astera Labs, Inc. has a 52 week low of $84.78 and a 52 week high of $315.81. The company’s 50-day moving average price is $170.39 and its 200 day moving average price is $159.79.

Astera Labs (NASDAQ:ALAB – Get Free Report) last released its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. The firm had revenue of $308.36 million for the quarter, compared to the consensus estimate of $292.19 million. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The firm’s revenue was up 93.5% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.33 earnings per share. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, equities research analysts expect that Astera Labs, Inc. will post 1.84 earnings per share for the current year.

Astera Labs News Summary

Here are the key news stories impacting Astera Labs this week:

Positive Sentiment: Evercore ISI raised its price target on Astera Labs to $297 from $215 and kept an Outperform rating after updated AI channel checks, reinforcing the market’s view that ALAB is benefiting from strong AI infrastructure demand. Article Title
Positive Sentiment: Multiple reports point to momentum from the AI inference boom, with traders and investors buying into the stock after bullish coverage, elevated call activity, and a “golden cross” technical breakout that can attract trend-following buyers. Article Title
Positive Sentiment: Recent commentary highlighted Astera Labs as a beneficiary of rising AI infrastructure spending, supporting the stock’s move higher and helping it reach fresh highs. Article Title
Neutral Sentiment: Executives including the CEO, COO, and general counsel disclosed large share sales, but several transactions were tied to pre-arranged 10b5-1 plans or tax withholding on equity awards, which makes the selling less conclusive as a bearish signal. Article Title

About Astera Labs

(Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.